TipRanks
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1

Compare Vertex Pharmaceuticals (VX1) vs. Competitors

23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
€475.00
€117.86B
30.19
31.35%
21 Buy
3 Hold
1 Sell
Strong Buy
Alnylam Pharma
$240.08
$34.00B
40.45
-49.81%
18 Buy
4 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$11.59B
157.89
6.53%
17 Buy
5 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$1.97B
-12.65
-9.06%
4 Buy
9 Hold
4 Sell
Hold
Intellia Therapeutics
$13.51
$1.69B
-3.59
-35.39%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.41B
-11.62
-16.20%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:VX1
Vertex Pharmaceuticals
455.20
104.90
29.95%
ALNY
Alnylam Pharma
231.18
-229.81
-49.85%
BMRN
BioMarin Pharmaceutical
58.44
2.87
5.16%
SRPT
Sarepta Therapeutics
17.57
-4.78
-21.39%
NTLA
Intellia Therapeutics
12.12
-8.32
-40.70%
CRSP
Crispr Therapeutics AG
55.44
-17.38
-23.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts